J&J recalls injection pens

    Johnson & Johnson is recalling a bad batch of injection pens manufactured at its Centocor Ortho Biotech unit in Horsham, Pa. This recall is the latest in a series for Johnson & Johnson, headquartered in New Brunswick, N.J., in recent weeks.

    The pens are preloaded with Simponi, a drug used to treat rheumatoid arthritis. About 400 have been recalled, only 165 of them in the United States.

    A Centocor representative said there is nothing wrong with the drug inside the pens, but a manufacturer’s defect may prevent a patient from getting the entire dose.

    Monica Neufang of Centocor she said there is a built-in safety feature because the nature of arthritis makes it difficult for some patients to grip.

    • WHYY thanks our sponsors — become a WHYY sponsor

    “The auto injector itself is designed to display a yellow indicator in the viewing window once the injection is complete,” she said. “If there is not an appearance of a yellow indicator, it means that the injection has not been fully dispensed. It’s very easy for a patient to see they achieved a full dose.”

    She said patients should consult a doctor before trying again. Centocor said the supply will be replenished by the end of March.

    Since December Johnson & Johnson has recalled four products including hernia devices and cracked syringes.

    WHYY is your source for fact-based, in-depth journalism and information. As a nonprofit organization, we rely on financial support from readers like you. Please give today.

    Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

    Together we can reach 100% of WHYY’s fiscal year goal